Report: Novo Nordisk and Hims plan to announce a partnership as early as next Monday, with Novo Nordisk selling weight loss drugs on the Hims platform

According to informed sources, Novo Nordisk plans to sell its weight loss medication on the Hims & Hers Health Inc. platform, thereby ending a highly publicized dispute between the two companies that escalated into legal action last month. The anonymous source stated that Novo Nordisk and Hims may announce a new partnership as early as next Monday. The two companies had reached a similar agreement last year, but Novo Nordisk unilaterally terminated the agreement after Hims refused to stop marketing and selling generic versions of the medication. (Bloomberg)